The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Early clinical safety and pharmacokinetics data of DZD1516, an BBB-penetrant selective HER2 inhibitor for the treatment of HER2-positive metastatic breast cancer.

Xichun  Hu

Honoraria - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Hengrui Pharmaceutical; Lilly; Merck; Novartis; Pfizer; Roche

Consulting or Advisory Role - AstraZeneca; Novartis

Jian  Zhang

No Relationships to Disclose

Nicholas Patrick  McAndrew

Honoraria - Daiichi Sankyo

Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo; Genomic Health; Novartis

Speakers' Bureau - Novartis

Research Funding - Daiichi Sankyo (Inst); Dizal Pharma (Inst); Novartis (Inst)

Travel, Accommodations, Expenses - Daiichi Sanko; Roche; TRIO US